ES
Eric Swayze (EVP Research) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $1.9M of IONS (23,463 sh across 2 lots, as filed), executed Jan 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Jun 25
Filed Jun 26
Median ADV $142.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
IONS
Ionis Pharmaceuticals, Inc.
IONS · 0 buys · 9 sells
9 filings
Recent filings
IONSSALE
Ionis Pharmaceuticals, Inc.
View filing →
$235K7,154 sh × $32.84
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET